Media Center
Press Releases

Press Releases

23 Jul 15
Type 2 Diabetes Mellitus Treatment Market Value Will Reach $39 Billion by 2021, says GBI Research

The global market for Type 2 Diabetes Mellitus (T2DM) therapeutics will rise in value from $23.5 billion in 2014 to an estimated $39 billion by 2021, driven primarily by rising disease prevalence and the continued uptake of recently approved and emerging branded treatments, according to business intelligence provider GBI Research.

Read post
14 Jul 15
Anti-hypertensive Therapeutics Market Value in Asia-Pacific to Approach $20 Billion by 2021

The anti-hypertensive therapeutics market in the Asia-Pacific (APAC) countries of Australia, India, China, and Japan will expand in value from $15.7 billion in 2014 to reach $19.9 billion by 2021, representing a Compound Annual Growth Rate (CAGR) of 3.4%, according to business intelligence provider GBI Research.

Read post
07 Jul 15
Contract Research Organization Deals Value Reached Almost $10 Billion between January and April 2015

The total number of deals in the global Contract Research Organization (CRO) market reached 700 between January 2010 and April 2015, achieving an overall value of $33 billion.

Read post
30 Jun 15
Global Biosimilars Market Value Could Hit $55 Billion by 2020, says GBI Research

The global biosimilars market value is expected to reach $20 billion by the end of 2015 and could hit $55 billion by 2020, with growth primarily driven by a promising pipeline in active development and government efforts to reduce healthcare spending, according to business intelligence provider GBI Research.

Read post
17 Jun 15
Pancreatic Cancer Treatment Pipeline Dominated by Early-Stage Development, says GBI Research

While the treatment pipeline for pancreatic cancer shows a high level of innovation, with 52% of products categorized as first-in-class, most development is in the early stages, meaning a significant proportion of therapies are unlikely to reach the market in the near future.

Read post